speb/financial-data huggingface dataset:
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 164420000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 164420000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 172960000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -18100000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -18100000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 261790000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 164420000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Operating Income: 186320000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 841050000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 23160000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 235470000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 201870000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 224620000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 41820000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 28910000.00
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.14
HESTERBIO.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 654730000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 442860000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 709690000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 285340000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 926430000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 407330000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 8575074.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 16.85
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 59980000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 85070000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 62900000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 281580000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 85070000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3379090000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 1820770000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 193190000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 2037220000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2710000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 940580000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 943290000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1413870000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 14780000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 43540000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 43540000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 8575074.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 16.85
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 144490000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — EBIT: 192430000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — EBITDA: 235970000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 77600000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 4217010000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 516500000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 22070000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 22070000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 658690000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 5455250000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 407330000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 57270000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1135580000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1192850000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 26370000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 131270000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 1180000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 2013260000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Net Income: 144490000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 144490000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 143310000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 144490000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 144490000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 143310000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -22070000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -22070000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 4217010000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3301490000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 68090000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 235970000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 144490000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Operating Income: 73640000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 709690000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 8506865.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 165600000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 55380000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 3294020000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 77600000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 12680000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 530350000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 97270000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 244310000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 2396240000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 4920000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 218680000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Payables: 296470000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 170360000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 193190000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 43540000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 8506865.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3379090000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 3301490000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 27050000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.16
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 6751840000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 4514670000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2136140000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3510360000.00
HESTERBIO.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 636050000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3241480000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 4714620000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1827610000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 11130000.00
HESTERBIO.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 623350000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 433250000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 774150000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 8011883.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 10.94
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 207280000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 44310000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 44310000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 8011883.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 10.94
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 87650000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — EBIT: 153460000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — EBITDA: 197770000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 566870000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 18220000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 18220000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -5450000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Net Income: 87650000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 87650000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 93100000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 87650000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 87650000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 93100000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -18220000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -18220000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 197770000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 87650000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Operating Income: 133620000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 774150000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 6690000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 233760000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 135240000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 207280000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 44310000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 42140000.00
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.31
HESTERBIO.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 640530000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — +Operating Expense: 1611100000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 522420000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — +Total Revenue: 3325990000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 1001100000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 246800000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 246800000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 953560000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 953560000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -1733520000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1733520000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 175070000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 175070000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -37840000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -37840000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 2380000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 448630000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 448630000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 8506865.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 8216967.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Basic EPS: 65.40
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 19.45
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 55870000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 1987460000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 1987460000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -178280000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: -178280000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 65390000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 65390000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 85070000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 85070000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 27670000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 27670000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 29410000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 29410000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -60260000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 27670000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 27670000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -35520000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 11500000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 27160000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Change In Payable: -31190000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -289990000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -311450000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 124780000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Common Stock: 85070000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 85070000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 3602350000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 3602350000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 25320000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 25320000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 943630000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 194500000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Current Assets: 2085620000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 2085620000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 2280000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 2280000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Current Debt: 982910000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 982910000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 985190000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 985190000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Current Deferred Taxes Liabilities: 50020000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 50020000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1524780000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1524780000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Depreciation: 186430000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 188810000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 188810000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 59140000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 188810000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 59140000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 8506865.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 8216967.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Diluted EPS: 65.40
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 19.45
HESTERBIO.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 556390000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 159820000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 3070000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 3070000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — EBIT: 832520000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — EBIT: 301830000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — EBITDA: 1021330000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — EBITDA: 360970000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: -148800000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — End Cash Position: 27670000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -487940000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 359380000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 359380000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 463130000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -17570000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: -29360000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 2040000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 83460000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 97220000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 97220000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 991400000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 991400000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 5869460000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 5869460000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Gross Profit: 2382360000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 806600000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Interest Expense: 74160000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 50950000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 74160000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 50950000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Interest Income: 15790000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 15790000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -66410000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 20310000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Inventory: 725330000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 725330000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 5484900000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 5484900000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -28690000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 0.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 0.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Investmentsin Joint Venturesat Cost: 425750000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Joint Venturesat Cost: 425750000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 83540000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 83540000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 63110000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 63110000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 899640000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 899640000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 962750000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 962750000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -305600000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 425750000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 425750000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 23360000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 23360000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 3704210000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 3704210000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 75540000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 75540000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Minority Interests: -18450000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -5640000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 79600000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Net Debt: 1854880000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 1854880000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 108950000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Net Income: 556390000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Net Income: 159820000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 556390000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 159820000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 574840000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 165460000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 556390000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 159820000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 556390000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 159820000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 758360000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 574840000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 165460000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Net Interest Income: -64460000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -50950000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -9190000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -358530000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -305600000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -64460000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -50950000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -9190000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Net PPE: 4135940000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 4135940000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 3870000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -52930000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 3505130000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 3505130000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Non Current Accrued Expenses: 0.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Non Current Accrued Expenses: 0.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 492320000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 492320000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 88080000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 88080000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 23360000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 23360000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 27930000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 27930000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1059670000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 331610000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Normalized Income: 585451877.74
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 140456536.99
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 641410000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Operating Income: 771260000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Operating Income: 284180000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Operating Revenue: 3325990000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1001100000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 8506865.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 8506865.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: -4180000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 130760000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 130760000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 87560000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 87560000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 3517280000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 3517280000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 97220000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 97220000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 42060000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 42060000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 79240000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 2010000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 2010000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 492320000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 492320000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 7000000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -30280000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 416470000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 299620000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Other Payable: 165620000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 165620000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Other Properties: 68930000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 68930000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 58420000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 58420000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 1740000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 1740000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Other Special Charges: -44890000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Payables: 415490000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Payables: 415490000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15290000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15290000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 253760000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 253760000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Pretax Income: 758360000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 250880000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 31350000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 113220000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 113220000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 943630000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 194500000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 188810000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 59140000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 29990000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 29990000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -358530000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 37710000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 37710000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 2867280000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 2867280000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Sale Of Business: 79600000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 3870000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 271670000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 355130000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Share Issued: 8506865.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 8506865.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Short Term Debt Payments: -52930000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Special Income Charges: -38340000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 29360000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 3602350000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 3602350000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 3505130000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 3505130000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -9278122.26
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 9996536.99
HESTERBIO.NS income_statement (annual, 2026-03-31) — Tax Provision: 183520000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 85420000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.24
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.34
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 27430000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 27430000.00
HESTERBIO.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -141240000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Total Assets: 6779410000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 6779410000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 4501990000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 4501990000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Total Debt: 1947940000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1947940000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 3677890000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 3677890000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Total Expenses: 2554730000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 716920000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 3101520000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3101520000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 4693790000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 4693790000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1576740000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1576740000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 6090000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -38340000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 29360000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -38340000.00
HESTERBIO.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 29360000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Work In Process: 210670000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 210670000.00
HESTERBIO.NS balance_sheet (annual, 2026-03-31) — Working Capital: 560840000.00
HESTERBIO.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 560840000.00
HESTERBIO.NS income_statement (annual, 2026-03-31) — Write Off: 83230000.00
HEVI.V income_statement (annual, 2021-12-31) — Basic Average Shares: 78738474.00
HEVI.V income_statement (annual, 2021-12-31) — Basic EPS: -0.06
HEVI.V balance_sheet (annual, 2021-12-31) — Cash Financial: 229.00
HEVI.V cash_flow (annual, 2021-12-31) — Change In Payables And Accrued Expense: 139722.00
HEVI.V cash_flow (annual, 2021-12-31) — Change In Receivables: 5245.00
HEVI.V income_statement (annual, 2021-12-31) — Diluted Average Shares: 78738474.00
HEVI.V income_statement (annual, 2021-12-31) — Diluted EPS: -0.06
HEVI.V income_statement (annual, 2021-12-31) — Interest Expense: 7897.00
HEVI.V income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 7897.00
HEVI.V income_statement (annual, 2021-12-31) — Interest Income: 0.00
HEVI.V income_statement (annual, 2021-12-31) — Interest Income Non Operating: 0.00
HEVI.V cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 1270000.00
HEVI.V cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
HEVI.V cash_flow (annual, 2021-12-31) — Operating Gains Losses: -30671.00
HEVI.V balance_sheet (annual, 2021-12-31) — Other Equity Interest: 552000.00
HEVI.V income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: 347681.00
HEVI.V balance_sheet (annual, 2021-12-31) — Other Payable: 12300000.00
HEVI.V balance_sheet (annual, 2021-12-31) — Restricted Cash: 12300000.00
HEVI.V income_statement (annual, 2021-12-31) — Restructuring And Mergern Acquisition: 0.00
HEVI.V cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
HEVI.V cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
HEVI.V balance_sheet (annual, 2021-12-31) — Taxes Receivable: 6072.00
HEVI.V income_statement (annual, 2021-12-31) — Total Other Finance Cost: 1000.00
HEVI.V cash_flow (annual, 2021-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
HEVI.V income_statement (annual, 2022-12-31) — +Operating Expense: 6221000.00
HEVI.V income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
HEVI.V balance_sheet (annual, 2022-12-31) — Accounts Payable: 163000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Accounts Receivable: 263000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -61000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 930000.00
HEVI.V cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 8000.00
HEVI.V income_statement (annual, 2022-12-31) — Basic Average Shares: 78397100.00
HEVI.V income_statement (annual, 2022-12-31) — Basic EPS: -0.09
HEVI.V cash_flow (annual, 2022-12-31) — Beginning Cash Position: 171000.00
HEVI.V cash_flow (annual, 2022-12-31) — Capital Expenditure: -6116000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 29000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Capital Stock: 19216000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 9128000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 9128000.00
HEVI.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 17479000.00
HEVI.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -7079000.00
HEVI.V cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -1443000.00
HEVI.V cash_flow (annual, 2022-12-31) — Change In Working Capital: -285000.00
HEVI.V cash_flow (annual, 2022-12-31) — Changes In Cash: 8957000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Common Stock: 19216000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Common Stock Equity: 12796000.00
HEVI.V cash_flow (annual, 2022-12-31) — Common Stock Issuance: 17640000.00
HEVI.V income_statement (annual, 2022-12-31) — Cost Of Revenue: 51000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Current Assets: 10419000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 20000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 20000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Current Liabilities: 183000.00
HEVI.V cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 51000.00
HEVI.V income_statement (annual, 2022-12-31) — Diluted Average Shares: 78397100.00
HEVI.V income_statement (annual, 2022-12-31) — Diluted EPS: -0.09
HEVI.V income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -7363000.00
HEVI.V income_statement (annual, 2022-12-31) — EBIT: -6272000.00
HEVI.V income_statement (annual, 2022-12-31) — EBITDA: -6221000.00
HEVI.V cash_flow (annual, 2022-12-31) — End Cash Position: 9128000.00
HEVI.V cash_flow (annual, 2022-12-31) — Financing Cash Flow: 17479000.00
HEVI.V cash_flow (annual, 2022-12-31) — Free Cash Flow: -7559000.00
HEVI.V income_statement (annual, 2022-12-31) — General And Administrative Expense: 1743000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Gross PPE: 2664000.00
HEVI.V income_statement (annual, 2022-12-31) — Gross Profit: -51000.00
HEVI.V income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 8000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Invested Capital: 12796000.00
HEVI.V cash_flow (annual, 2022-12-31) — Investing Cash Flow: -7079000.00
HEVI.V cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 17640000.00
HEVI.V cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1500000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 9000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 9000.00
HEVI.V cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 17640000.00
HEVI.V cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -19000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Long Term Provisions: 34000.00
HEVI.V cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 17640000.00
HEVI.V income_statement (annual, 2022-12-31) — Net Income: -7363000.00
HEVI.V income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -7363000.00
HEVI.V income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -7363000.00
HEVI.V income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -7363000.00
HEVI.V income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -7363000.00
HEVI.V cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -7363000.00
HEVI.V income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -7363000.00
HEVI.V income_statement (annual, 2022-12-31) — Net Interest Income: 155000.00
HEVI.V cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -19000.00
HEVI.V cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -19000.00
HEVI.V income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 155000.00
HEVI.V cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -142000.00
HEVI.V cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -963000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Net PPE: 2603000.00
HEVI.V cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -6116000.00
HEVI.V cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 0.00
HEVI.V balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 12796000.00
HEVI.V income_statement (annual, 2022-12-31) — Normalized EBITDA: -4975000.00
HEVI.V income_statement (annual, 2022-12-31) — Normalized Income: -6117000.00
HEVI.V cash_flow (annual, 2022-12-31) — Operating Cash Flow: -1443000.00
HEVI.V income_statement (annual, 2022-12-31) — Operating Income: -6272000.00
HEVI.V income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
HEVI.V balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 96033974.00
HEVI.V balance_sheet (annual, 2022-12-31) — Other Current Assets: 992000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Other Equity Interest: 1425000.00
HEVI.V income_statement (annual, 2022-12-31) — Other Gand A: 971000.00
HEVI.V income_statement (annual, 2022-12-31) — Other Income Expense: -1246000.00
HEVI.V cash_flow (annual, 2022-12-31) — Other Non Cash Items: 5620000.00
HEVI.V income_statement (annual, 2022-12-31) — Other Operating Expenses: 4478000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Other Properties: 2664000.00
HEVI.V income_statement (annual, 2022-12-31) — Other Special Charges: 1142000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Payables: 163000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 163000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Prepaid Assets: 36000.00
HEVI.V income_statement (annual, 2022-12-31) — Pretax Income: -7363000.00
HEVI.V cash_flow (annual, 2022-12-31) — Purchase Of PPE: -6116000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Receivables: 263000.00
HEVI.V income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 51000.00
HEVI.V income_statement (annual, 2022-12-31) — Reconciled Depreciation: 51000.00
HEVI.V cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1519000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Restricted Cash: 0.00
HEVI.V income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 96000.00
HEVI.V balance_sheet (annual, 2022-12-31) — Retained Earnings: -8775000.00